New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 12, 2014
16:31 EDTHAEHaemonetics sees margin headwinds from lower pricing, announces supply pact
Haemonetics announced that it has entered into a multi-year agreement to supply the HemeXcel Purchasing Alliance with certain whole blood collection components on an exclusive basis during calendar years 2014-2016. The announcement was made in conjunction with the 32nd Annual J.P. Morgan Health Care Conference in San Francisco. Haemonetics indicated that this incremental business volume will not have a material impact on fiscal 2014 revenue or earnings. Considered together with a smaller recent U.S. tender that was not awarded to Haemonetics, this incremental volume will represent approximately five net points of U.S. whole blood disposables share gain in fiscal 2015 and beyond. Another major U.S. whole blood tender remains in process and is expected to be awarded early in calendar 2014. Haemonetics continues to work closely with this customer and is excited to have the opportunity to show its full range of capabilities. Brian Concannon, Haemonetics' President and CEO said, "The North American whole blood market is in a period of rapid change in which significantly reduced demand for blood products is driving collector consolidation and aggressive competitive pricing for whole blood consumables. While we are optimistic about what these trends mean for the introduction of our differentiated whole blood offering, we expect margin headwinds from lower pricing will more than offset any benefit related to this share gain in fiscal 2015. As we progress through the fiscal years beyond 2015, benefits of product value engineering and other internal initiatives are expected to offset these margin headwinds."
News For HAE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 5, 2015
18:56 EDTHAEOn The Fly: After Hours Movers
HIGHER: Regulus Therapeutics (RGLS), up 8.7% after the company announced that it will present new preclinical data on RG-012 for kidney disease... Palatin Technologies (PTN), up 9.6% after director Robert deVeer Jr. buys 10,000 shares of common stock... Arena Pharmaceuticals (ARNA), up 4.7% after CEO Jack Lief announced his retirement and Harry Hixson was named interim CEO... DuPont (DD), up 5.9% after CEO and chair Ellen Kullman retires... Ruckus Wireless (RKUS), up 4.9% after joining the S&P 600... Starz (STRZA), up 10.1% after the LA Times reports that Lionsgate (LGF) is in advanced talks to merge with Starz. DOWN AFTER EARNINGS: Container Store (TCS), down 10.4%. ALSO LOWER: Sarepta Therapeutics (SRPT), down 3.8% after filing to sell $125M of common stock... Haemonetics (HAE), down 12.2% after lowering its fiscal 2016 outlook... Energy XXI (EXXI), down 8.3% after filing a $500M mixed securities shelf... Mallinckrodt (MNK), down 1.6% after announcing that it will provide a business update and financial guidance for the fiscal year ending September 30, 2016, on an investor call on October 6.
16:48 EDTHAEHaemonetics sees FY16 constant currency revenue growth approximately 4%
Down from prior view of 7%-9% constant currency revenue growth for FY16. Revenue consensus for FY16 is $946.75M.
16:40 EDTHAEHaemonetics says shortfall in 2H16 revenue due to deterioration in Russia
Subscribe for More Information
16:38 EDTHAEHaemonetics lowers FY16 adjusted EPS view to $1.65-$1.75 from $1.98-$2.08
Subscribe for More Information
16:36 EDTHAEHaemonetics sees Q2 adjusted EPS approximately 40c, consensus 39c
Subscribe for More Information
16:36 EDTHAEHaemonetics lowers FY16 outlook
Subscribe for More Information
September 29, 2015
16:38 EDTHAEHaemonetics CEO Brian Concannon resigns, Ron Gelman appointed interim CFO
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use